We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current 0RGO market cap is 1.85T. The company's latest EPS is EUR -0.0005 and P/E is -2485120.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.08M | 370k | 36.86M | 35.51M | 40.76M |
| Operating Income | -15.95M | -665k | 536k | -3.58M | 277k |
| Net Income | -15.66M | -1.36M | -241k | -5.58M | -709k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 6.81M | 5.14M | 36.3M | 39.89M | 43.76M |
| Total Liabilities | 10.98M | 10.77M | 25.41M | 29.25M | 33.87M |
| Total Equity | -4.18M | -5.64M | 10.89M | 10.64M | 9.89M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -12.98M | -1.38M | 348k | 2.33M | -2.27M |
| Investing | -95k | 638k | -1.34M | -992k | -1.51M |
| Financing | 8.26M | -59k | 2M | 471k | 3.74M |
| Market Cap | 1.85T |
| Price to Earnings Ratio | -2485120.00 |
| Price to Sales Ratio | 45.35k |
| Price to Cash Ratio | 443.77k |
| Price to Book Ratio | 187.11k |
| Dividend Yield | - |
| Shares Outstanding | 1.49B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 1,242.56 |
| 52 Week Low | 1,242.56 |
| Spread (Intraday) | 0 (0%) |
| Company Name | European Medical Solutions |
| Address |
9 avenue du canal philippe lamour la garde, var 30660 |
| Website | https://www.european-medical-solutions.eu |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
